These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33477954)

  • 1. Low Luminance Visual Acuity and Low Luminance Deficit in Proliferative Diabetic Retinopathy.
    Karatsai E; Sen P; Gurudas S; Sivaprasad S
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting vision gains with anti-VEGF therapy in neovascular age-related macular degeneration patients by using low-luminance vision.
    Frenkel RE; Shapiro H; Stoilov I
    Br J Ophthalmol; 2016 Aug; 100(8):1052-7. PubMed ID: 26541435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.
    Sivaprasad S; Prevost AT; Vasconcelos JC; Riddell A; Murphy C; Kelly J; Bainbridge J; Tudor-Edwards R; Hopkins D; Hykin P;
    Lancet; 2017 Jun; 389(10085):2193-2203. PubMed ID: 28494920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-luminance visual acuity and microperimetry in age-related macular degeneration.
    Wu Z; Ayton LN; Guymer RH; Luu CD
    Ophthalmology; 2014 Aug; 121(8):1612-9. PubMed ID: 24661863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.
    Allingham MJ; Mettu PS; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100095. PubMed ID: 36246187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal vein changes after treatment with aflibercept and PRP in high-risk proliferative diabetic retinopathy.
    Zhao H; Wang J; Li S; Bao Y; Zheng X; Tao Y; Wang H
    Front Med (Lausanne); 2023; 10():1090964. PubMed ID: 36968838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Cataract Surgery on Low Luminance Visual Acuity Deficit Measurements.
    Shen M; Shi Y; Wang L; Russell JF; Jiang X; Laiginhas R; Iyer P; Trivizki O; Thulliez M; Yoo SH; Rose TP; Habash RG; Amescua G; Feuer WJ; Gregori G; Rosenfeld PJ
    Ophthalmol Sci; 2022 Sep; 2(3):100170. PubMed ID: 36245760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploratory Study on Visual Acuity and Patient-Perceived Visual Function in Patients with Subretinal Drusenoid Deposits.
    Grewal MK; Chandra S; Gurudas S; Bird A; Jeffery G; Sivaprasad S
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32882940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pan retinal photocoagulation on central macular thickness and visual acuity in proliferative diabetic retinopathy.
    Mukhtar A; Khan MS; Junejo M; Ishaq M; Akbar B
    Pak J Med Sci; 2016; 32(1):221-4. PubMed ID: 27022379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.
    Mettu PS; Allingham MJ; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100086. PubMed ID: 36246181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
    Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
    Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study.
    Garweg JG; Stefanickova J; Hoyng C; Schmelter T; Niesen T; Sowade O; Sivaprasad S;
    Ophthalmol Retina; 2019 Jul; 3(7):567-575. PubMed ID: 31080168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser photocoagulation for proliferative diabetic retinopathy.
    Evans JR; Michelessi M; Virgili G
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011234. PubMed ID: 25420029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy.
    Sameen M; Khan MS; Mukhtar A; Yaqub MA; Ishaq M
    Pak J Med Sci; 2017; 33(1):142-145. PubMed ID: 28367188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of multifocal electroretinography and optical coherence tomography in eyes undergoing panretinal photocoagulation for diabetic retinopathy.
    Zhu Y; Zhang T; Wang KY; Xu GZ
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6358-64. PubMed ID: 25146984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
    Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
    Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
    JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New perspectives in the approach to diabetic macular edema. Aflibercept therapy].
    Ruiz-Moreno JM
    Arch Soc Esp Oftalmol; 2015 Mar; 90 Suppl 1():24-8. PubMed ID: 25925048
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.